Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Dow
Harvard Business School
McKesson
Merck

Last Updated: June 25, 2022

Drug Price Trends for CYCLOPHOSPHAMIDE


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for CYCLOPHOSPHAMIDE

Average Pharmacy Cost for CYCLOPHOSPHAMIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CYCLOPHOSPHAMIDE 50 MG CAPSULE 62559-0931-01 8.05093 EACH 2020-11-04
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CYCLOPHOSPHAMIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CYCLOPHOSPHAMIDE 25MG CAP Hikma Pharmaceuticals USA Inc. 00054-0382-25 100 267.57 2.67570 EACH 2021-08-15 - 2026-08-14 Big4
CYCLOPHOSPHAMIDE 25MG CAP Hikma Pharmaceuticals USA Inc. 00054-0382-25 100 541.95 5.41950 EACH 2021-08-15 - 2026-08-14 FSS
CYCLOPHOSPHAMIDE 25MG CAP Hikma Pharmaceuticals USA Inc. 00054-0382-25 100 288.30 2.88300 EACH 2022-01-01 - 2026-08-14 Big4
CYCLOPHOSPHAMIDE 50MG CAP Hikma Pharmaceuticals USA Inc. 00054-0383-25 100 451.98 4.51980 EACH 2021-08-15 - 2026-08-14 Big4
CYCLOPHOSPHAMIDE 50MG CAP Hikma Pharmaceuticals USA Inc. 00054-0383-25 100 994.61 9.94610 EACH 2021-08-15 - 2026-08-14 FSS
CYCLOPHOSPHAMIDE 50MG CAP Hikma Pharmaceuticals USA Inc. 00054-0383-25 100 502.75 5.02750 EACH 2022-01-01 - 2026-08-14 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
McKesson
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.